Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.

[1]  N. Mcintyre,et al.  Oxford Textbook of Clinical Hepatology , 1999 .

[2]  T. Takano,et al.  Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor* , 1997, The Journal of Biological Chemistry.

[3]  C. Serhan.  Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? , 1997, Prostaglandins.

[4]  R. Dargel,et al.  Oxygen radical formation, proliferative activity and phagocytic capacity of cultivated macrophages from cirrhotic rat livers. , 2008, Liver.

[5]  J. Berliner,et al.  Angiotensin II increases monocyte binding to endothelial cells. , 1996, Biochemical and biophysical research communications.

[6]  C. Serhan,et al.  Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. , 1996, Journal of immunology.

[7]  J. Haeggström,et al.  Lipid mediator networks in cell signaling: update and impact of cytokines 1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[9]  J. Bousquet,et al.  5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors , 1996, The Journal of experimental medicine.

[10]  C. Serhan,et al.  Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. , 1996, Journal of immunology.

[11]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[12]  C. Serhan,et al.  Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction , 1996, The Journal of experimental medicine.

[13]  C. Serhan,et al.  Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Zijlstra,et al.  Levels of soluble intercellular adhesion molecule 1, eicosanoids and cytokines in ascites of patients with liver cirrhosis, peritoneal cancer and spontaneous bacterial peritonitis. , 1995, International journal of immunopharmacology.

[15]  D. Keppler,et al.  Cysteinyl leukotrienes in the urine of patients with liver diseases , 1994, Hepatology.

[16]  C. Serhan,et al.  Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. , 1993, The Journal of clinical investigation.

[17]  J. Rossi,et al.  Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Llach,et al.  Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration , 1992, Hepatology.

[19]  F. Wolber,et al.  A simple method for the purification of human peripheral blood monocytes. A substitute for Sepracell-MN. , 1991, Journal of immunological methods.

[20]  J. Nadel,et al.  Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. , 1991, The Journal of clinical investigation.

[21]  C. Serhan,et al.  Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils , 1990, The Journal of experimental medicine.

[22]  C. Dollery,et al.  Increased production of cysteinyl leukotrienes in hepatorenal syndrome. , 1990, Journal of hepatology.

[23]  C. Serhan,et al.  Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. , 1990, The Journal of clinical investigation.

[24]  B. Spur,et al.  Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.

[25]  K. Badr,et al.  Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Dixon,et al.  Molecular cloning and primary structure of human 15-lipoxygenase. , 1988, Biochemical and biophysical research communications.

[27]  B. Runyon.  Spontaneous bacterial peritonitis: An explosion of information , 1988, Hepatology.

[28]  R. Dixon,et al.  Cloning of the cDNA for human 5-lipoxygenase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[30]  I. Rajkovic,et al.  Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis , 1986, Hepatology.

[31]  I. Bonta,et al.  Production of leukotrienes and prostaglandins by human ascites cells , 1985, European journal of clinical investigation.

[32]  D. Keppler,et al.  The relation of leukotrienes to liver injury , 1985, Hepatology.

[33]  V. Arroyo,et al.  Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis , 1984, Hepatology.

[34]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[35]  B. Hancock,et al.  Neutrophil and Monocyte Phagocytosis in Chronic Liver Disease , 1982 .

[36]  G. Holdstock,et al.  Monocyte function in cirrhosis. , 1982, Journal of clinical pathology.

[37]  S. Shibolet,et al.  Impaired monocyte function in liver cirrhosis. , 1981, Lancet.

[38]  V. Arroyo,et al.  Renin, aldosterone and renal haemodynamics in cirrhosis with ascites , 1979, European journal of clinical investigation.

[39]  M. Gougerot,et al.  Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis , 1977, European journal of clinical investigation.

[40]  P. Ward,et al.  Defective regulation of chemotaxis in cirrhosis. , 1975, The Journal of laboratory and clinical medicine.

[41]  A. Br,et al.  Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. , 1972 .

[42]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[43]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.